DE60233161D1 - Medium zur radikalen therapie von tumoren, von entzündungsprozessen, von pilzinfektionen und von andophylaktische verfahren sowie deren implementierung - Google Patents
Medium zur radikalen therapie von tumoren, von entzündungsprozessen, von pilzinfektionen und von andophylaktische verfahren sowie deren implementierungInfo
- Publication number
- DE60233161D1 DE60233161D1 DE60233161T DE60233161T DE60233161D1 DE 60233161 D1 DE60233161 D1 DE 60233161D1 DE 60233161 T DE60233161 T DE 60233161T DE 60233161 T DE60233161 T DE 60233161T DE 60233161 D1 DE60233161 D1 DE 60233161D1
- Authority
- DE
- Germany
- Prior art keywords
- tumors
- implementation
- medium
- inflammatory processes
- andophylactic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 206010028980 Neoplasm Diseases 0.000 title abstract 3
- 230000004054 inflammatory process Effects 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 208000024386 fungal infectious disease Diseases 0.000 title 1
- 238000002560 therapeutic procedure Methods 0.000 title 1
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 abstract 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 abstract 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 230000000844 anti-bacterial effect Effects 0.000 abstract 1
- 230000002421 anti-septic effect Effects 0.000 abstract 1
- 239000003899 bactericide agent Substances 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 230000023555 blood coagulation Effects 0.000 abstract 1
- 210000004204 blood vessel Anatomy 0.000 abstract 1
- 230000001112 coagulating effect Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 238000005755 formation reaction Methods 0.000 abstract 1
- 229910052740 iodine Inorganic materials 0.000 abstract 1
- 239000011630 iodine Substances 0.000 abstract 1
- 230000035772 mutation Effects 0.000 abstract 1
- 230000000069 prophylactic effect Effects 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0409—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is not a halogenated organic compound
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Oncology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| BG106215A BG106215A (bg) | 2001-12-12 | 2001-12-12 | Средство за радикално лечение на туморите, възпалителни процеси, гъбични образувания и други изменения на тъканите, диагностика и профилактика и методи за прилагането му |
| PCT/BG2002/000006 WO2003049728A1 (en) | 2001-12-12 | 2002-04-08 | Medium for radical treatment of tumors, inflammatory processes, fungal infections and other affections of the tissues, diagnostic and prophylactic and method of its implementation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE60233161D1 true DE60233161D1 (de) | 2009-09-10 |
Family
ID=3928598
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE60233161T Expired - Lifetime DE60233161D1 (de) | 2001-12-12 | 2002-04-08 | Medium zur radikalen therapie von tumoren, von entzündungsprozessen, von pilzinfektionen und von andophylaktische verfahren sowie deren implementierung |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20050119344A1 (de) |
| EP (1) | EP1455772B1 (de) |
| AT (1) | ATE437635T1 (de) |
| AU (1) | AU2002245956A1 (de) |
| BG (1) | BG106215A (de) |
| DE (1) | DE60233161D1 (de) |
| DK (1) | DK1455772T3 (de) |
| EA (1) | EA010029B1 (de) |
| ES (1) | ES2332583T3 (de) |
| PT (1) | PT1455772E (de) |
| WO (1) | WO2003049728A1 (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA201700154A1 (ru) * | 2014-10-20 | 2017-08-31 | Товарищество С Ограниченной Ответственностью "Фармацевтическая Компания "Ромат" | Фармацевтический состав лечебно-профилактического действия и способ его приготовления |
| KR20190137909A (ko) * | 2017-04-22 | 2019-12-11 | 차이동 친 | 세포 해당과 글루타민 대사과정 동시 억제방법 및 응용 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4147775A (en) * | 1976-10-06 | 1979-04-03 | Schwartz Stephen H | Antiseptic composition |
| LU86573A1 (de) * | 1986-09-08 | 1988-04-05 | Chimicasa Gmbh | Verfahren und praeparat zum inaktivieren von viren innerhalb lebender menschlicher oder tierischer organismen |
| US4927813A (en) * | 1988-03-08 | 1990-05-22 | Bernstein Joel E | Method and composition for treating pediculosis capitis |
| WO1994006297A1 (en) * | 1992-09-22 | 1994-03-31 | Arda Technologies, Co. | Antimicrobial composition and method of preparation |
| WO1997041434A1 (en) * | 1996-04-30 | 1997-11-06 | Peregrine Pharmaceutical, Inc. | Method for diagnosing cancer |
| US6231840B1 (en) * | 1998-02-13 | 2001-05-15 | Carol J. Buck | Compositions and methods for the topical treatment of nail fungi conditions |
| SE513436C2 (sv) * | 1999-01-21 | 2000-09-11 | Astrid Agholme | Användning av en beredning innehållande myrsyra för framställning av ett läkemedel för behandling av vårtor, orsakade av Papillomavirus |
-
2001
- 2001-12-12 BG BG106215A patent/BG106215A/bg unknown
-
2002
- 2002-04-08 DK DK02713949T patent/DK1455772T3/da active
- 2002-04-08 DE DE60233161T patent/DE60233161D1/de not_active Expired - Lifetime
- 2002-04-08 ES ES02713949T patent/ES2332583T3/es not_active Expired - Lifetime
- 2002-04-08 AT AT02713949T patent/ATE437635T1/de active
- 2002-04-08 WO PCT/BG2002/000006 patent/WO2003049728A1/en not_active Application Discontinuation
- 2002-04-08 EP EP02713949A patent/EP1455772B1/de not_active Expired - Lifetime
- 2002-04-08 US US10/496,322 patent/US20050119344A1/en not_active Abandoned
- 2002-04-08 AU AU2002245956A patent/AU2002245956A1/en not_active Abandoned
- 2002-04-08 EA EA200400783A patent/EA010029B1/ru not_active IP Right Cessation
- 2002-04-08 PT PT02713949T patent/PT1455772E/pt unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2002245956A1 (en) | 2003-06-23 |
| EA200400783A1 (ru) | 2005-04-28 |
| EP1455772A1 (de) | 2004-09-15 |
| BG106215A (bg) | 2003-06-30 |
| US20050119344A1 (en) | 2005-06-02 |
| PT1455772E (pt) | 2009-11-03 |
| EP1455772B1 (de) | 2009-07-29 |
| ES2332583T3 (es) | 2010-02-09 |
| WO2003049728A1 (en) | 2003-06-19 |
| DK1455772T3 (da) | 2009-11-30 |
| EA010029B1 (ru) | 2008-06-30 |
| ATE437635T1 (de) | 2009-08-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE468137T1 (de) | Inhibitoren von hmgb1 zur behandlung von gewebekrankheiten | |
| BRPI0213786B8 (pt) | peptídeos efetivos no tratamento de tumores e outras condições que requerem a remoção ou destruição de células | |
| DE60135755D1 (de) | Verbindungen und methoden zur behandlung von hautverletzungen | |
| ATE401575T1 (de) | Zusammensetzungen und verfahren zur diagnose und behandlung von kolonkrebs | |
| BRPI0414455A (pt) | métodos para usar células regenerativas no tratamento de doença vascular periférica e distúrbios afins | |
| WO2005065242A3 (en) | Method of treating cancer using platelet releasate | |
| ATE355852T1 (de) | Verwendung von botulinum toxin zur behandlung von herz- und kreislaufskrankheiten | |
| ATE409176T1 (de) | 1-phenylalkancarbonsäurederivate zur behandlung neurodegenerativer erkrankungen | |
| CY1110503T1 (el) | Πενταμιδινη για θεραπεια καρκινου | |
| ATE422357T1 (de) | Verwendung von allopurinol zur behandlung von bluthochdruck | |
| ATE430572T1 (de) | Verwendung von spongosin (2-methoxyadenosin) zur behandlung von schmerzen, insbesondere hyperalgesie | |
| ATE415962T1 (de) | Verwendung von asiatsäure oder asiaticosid zur behandlung von krebs | |
| ATE336997T1 (de) | Fulvinsäure und dessen verwendung zur behandlung von diversen krankheitszuständen | |
| ATE374618T1 (de) | Verwendung von rekombinanten menschlichen uteroglobin zur behandlung von fibrotischen krankheitszuständen | |
| ATE356995T1 (de) | Verfahren zur identifizierung von mitteln zur behandlung von diabetes | |
| DE69902520D1 (de) | Verwendung von selegilin oder desmethylselegilin zur behandlung von wunden, verbrennungen und hautschäden | |
| DE60309887D1 (de) | Kombination von einem aromatasehemmer mit einem bisphosphonat | |
| DE60233161D1 (de) | Medium zur radikalen therapie von tumoren, von entzündungsprozessen, von pilzinfektionen und von andophylaktische verfahren sowie deren implementierung | |
| WO2022271810A3 (en) | Bicyclic peptidyl pan-ras inhibitors | |
| DE50100833D1 (de) | Verwendung von 2-methyl-thiazolidin-2,4-dicarbonsäure und / oder ihrer physiologisch verträglichen salze zur herstellung eines medikaments zur behandlung von krebserkrankungen | |
| HUP0401188A2 (hu) | Hiperelágazásos amilopektin sebészeti, gyógyító vagy diagnosztikai eljárásokban emlősöknél való alkalmazásra, különösen plazmatérfogat-növelőként | |
| DE50211672D1 (de) | Urokinase-inhibitoren | |
| DE602004030661D1 (de) | Verwendung von kahalalide verbindungen zur herstellung eines arzneimittels zur behandlung von psoriasis | |
| DE60021111D1 (de) | Verwendung von fibrinolytischen metallproteinasen zur behandlung von blutgerinseln | |
| US6932966B1 (en) | Topically applied reconstituted ocean water mixture and method of producing and using the mixture |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition |